ALtruis e-Business Launched With Multiple Healthcare Websites And 1,000 Internet Domain Names

Sep 11, 2000, 01:00 ET from ALtruis LLC

    VESTAVIA HILLS, Ala., Sept. 11 /PRNewswire/ -- ALtruis (www.altruis.com ),
 an e-commerce company focusing on healthcare and biomedical research,
 announced the launch of the ALtruis Biomedical Network(SM) (ABN).  The ABN
 (www.altruisbiomedical.net ) consists of a novel business model and ca. 1,000
 registered Internet domain names, which help drive high volume traffic to
 numerous specialized healthcare Websites operated by ALtruis.
     This new hierarchical e-business Webring system provides to Internet
 visitors quality information (content) on various healthcare topics, coupled
 to relevant advertisements for products and services from vendors.  The ABN
 operates multiple topic-specific Websites in a broad range of categories, such
 as skincare, women's health, oncology, fitness, and biotechnology research and
 development.
     According to Thomas P. Dooley, Ph.D., the CEO and inventor -- "Our
 Websites are linked together like numerous grape clusters on a large vine,
 with each Website covering individual healthcare and research categories.  The
 hundreds of links within the ALtruis Biomedical Network can drive high volume
 Internet traffic through a proprietary method, with seamless access to
 virtually any healthcare topic of interest."
     From a business perspective, this new e-business model has many advantages
 over other potential e-commerce competitors, who typically operate a single
 Website.  Most potential competitors are facing challenges generating
 sufficient revenues to justify their high valuations, market caps, and capital
 burn rates.  Unlike them, the ABN is scalable, which permits incremental
 increases in the number of offered topic-specific Websites, perhaps exceeding
 100 within a year.  Furthermore, this patent-pending e-business model
 complements conventional bricks and mortar companies, such as pharmaceutical
 companies and retailers, and helps them present advertisements to a large
 captive Internet audience with genuine interest in the selected topics.
     Over the past month, the company has already launched dozens of ABN
 Websites.  Examples of the new Websites and topic areas include:
 
     EarthDerm.com -- dermatology and skincare
     Cancer-Drug.com -- oncology
     Allergy-Drug.com -- inflammation and allergy
     JockRash.com -- fitness and nutrition
     Anti-Biotic.com -- infectious diseases
     e-WomensHealth.net -- gynecology and breasts
     DNA-Arrays.com -- genome research
 
     ALtruis LLC is a privately held company in Vestavia Hills, Alabama,
 established by successful scientist-entrepreneurs with altruistic intentions.
 ALtruis commenced operations in January 1999, and anticipates being profitable
 within 2 years based on revenues from advertising and partners.  Both ALtruis
 and IntegriDerm, Inc. (www.integriderm.com ) were co-founded by Dr. Dooley and
 Jim Hudson, the founder of Research Genetics, Inc., a leader in products to
 the human genome research community and a subsidiary of Invitrogen Corp.
 ALtruis has a strategic alliance with IntegriDerm, which in turn has an
 alliance with Invitrogen / Research Genetics.
     Certain statements contained in this press release are considered
 "forward-looking statements" within the meaning of the Private Securities
 Litigation Reform Act of 1995, such as statements regarding profitability,
 benefits of association, product launches and company goals.  Such forward-
 looking statements are subject to a number of risks, uncertainties and other
 factors that could cause actual results to differ materially from future
 results expressed or implied by such forward-looking statements.  Potential
 risks and uncertainties include, but are not limited to delays or difficulties
 in obtaining sufficient revenues, or other legal or financial difficulties, as
 well as other risks and uncertainties.
 
 

SOURCE ALtruis LLC